The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
Open accessAbstract
Background: Prophylactic efficacy against colitis following lactobacillus consumption in interleukin 10 (IL-10) knockout (KO) mice has been reported. Whether this applies equally to other probiotic strains is unknown, and the mechanism is unclear. Aims: (1) To compare the effect of feeding Lactobacillus salivarius subspecies salivarius 433118 and Bifidobacterium infantis 35624 against placebo on enterocolitis, the intestinal microflora, and (2) to compare the systemic immunological response to in vitro microbial challenge in probiotic fed and control IL-10 KO mice. Methods: Three groups of 10 IL-10 KO mice were fed fermented milk products containing Lb salivarius 433118 at 10 9 CFU/ml, B infantis 35624 at 10 8 CFU/ml, and unmodified milk, respectively, for 19 weeks. Faecal samples were taken at regular intervals to confirm gut transit, recovery of fed probiotics, and to assess the impact on the microflora. At sacrifice, the bowels were histologically scored. Cytokine production from Peyers’ patches and splenocytes was measured in vitro by ELISA. Results: Faecal recovery of probiotics was confirmed in all probiotic fed mice but not in controls. Colonic and caecal inflammatory scores were significantly decreased in both groups of probiotic fed mice (p<0.05). Proinflammatory cytokine production by Peyers’ patches and splenocytes was significantly reduced in probiotic fed animals whereas transforming growth factor β (TGF-β) levels were maintained. Conclusion: Both Lactobacillus salivarius 433118 and Bifidobacterium infantis 35624 significantly attenuate colitis in this murine model. Attenuation of colitis is associated with a reduced ability to produce Th1-type cytokines systemically and mucosally, while levels of TGF-β are maintained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nucleic acid techniques in bacterial systematics
Stackebrandt, E. S., & Goodfellow, M. (1991) · Wiley eBooks · Cited by 9,460
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Zoetendal, E. G., Akkermans, A. D. L., & De Vos, W. M. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.10.3854-3859.1998 · Cited by 1,360
Rapid silver staining and recovery of PCR products separated on polyacrylamide gels.
Cj, S., Neto, E. D., & Aj, S. (1994) · PubMed · Cited by 1,177
Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
Dunne, C., O’Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O’Halloran, S., Feeney, M., Flynn, S., Fitzgerald, G., Daly, C., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.386s · Cited by 922
Self-citationFuller, R. (1991) · Gut · doi:10.1136/gut.32.4.439 · Cited by 862
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice
Madsen, K. L., Doyle, J. S., Jewell, L. D., Tavernini, M. M., & Fedorak, R. N. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70013-2 · Cited by 761
Heilig, H. G. H. J., Zoetendal, E. G., Vaughan, E. E., Marteau, P., Akkermans, A. D. L., & de Vos, W. M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.1.114-123.2002 · Cited by 676
Self-citation
Cited by
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Self-citationAntagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
Servin, A. L. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.01.003 · Cited by 1,236
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023) · Cells · doi:10.3390/cells12010184 · Cited by 889
Actinobacteria: A relevant minority for the maintenance of gut homeostasis
Binda, C., Lopetuso, L. R., Rizzatti, G., Gibiino, G., Cennamo, V., & Gasbarrini, A. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.02.012 · Cited by 815
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799
Self-citationMechanisms of action of probiotics: Recent advances
Ng, S. C., Hart, A. L., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20602 · Cited by 596
Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates
Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., & Hammerman, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.054 · Cited by 590
Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis
Westfall, S., Lomis, N., Kahouli, I., Dia, S. Y., Singh, S. P., & Prakash, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2550-9 · Cited by 541
Mechanisms of nutrient modulation of the immune response
Cunningham-Rundles, S., McNeeley, D. F., & Moon, A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.04.036 · Cited by 534
Immunomodulatory Effects of Probiotics on Cytokine Profiles
Azad, M. A. K., Sarker, M., & Wan, D. (2018) · BioMed Research International · doi:10.1155/2018/8063647 · Cited by 521
Borchers, A. T., Selmi, C., Meyers, F. J., Keen, C. L., & Gershwin, M. E. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2296-0 · Cited by 499
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482
“In the past years, probiotics have been shown to be effective in the treatment of mild to moderately active IBD [18] and to reduce inflammation in animal models of colitis [29,34–36].”
BackgroundPreidis, G. A., & Versalovic, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.072 · Cited by 485
Probiotic and other functional microbes: from markets to mechanisms
Saxelin, M., Tynkkynen, S., Mattila-Sandholm, T., & de Vos, W. M. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.02.003 · Cited by 484
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
ZOCCO, M. A., DAL VERME, L. Z., CREMONINI, F., PISCAGLIA, A. C., NISTA, E. C., CANDELLI, M., NOVI, M., RIGANTE, D., CAZZATO, I. A., OJETTI, V., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02927.x · Cited by 473
Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut
Groeger, D., O’Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2013) · Gut Microbes · doi:10.4161/gmic.25487 · Cited by 448
Self-citationCorrelation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria
Foligne, B. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i2.236 · Cited by 432
Kim, H. J., Vazquez Roque, M. I., Camilleri, M., Stephens, D., Burton, D. D., Baxter, K., Thomforde, G., & Zinsmeister, A. R. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00695.x · Cited by 400
Immunomodulatory Effects of Probiotics in the Intestinal Tract
(2008) · Current Issues in Molecular Biology · doi:10.21775/cimb.010.037 · Cited by 400
Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation
O'Mahony, C., Scully, P., O'Mahony, D., Murphy, S., O'Brien, F., Lyons, A., Sherlock, G., MacSharry, J., Kiely, B., Shanahan, F., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000112 · Cited by 364
Self-citationBousvaros, A., Guandalini, S., Baldassano, R. N., Botelho, C., Evans, J., Ferry, G. D., Goldin, B., Hartigan, L., Kugathasan, S., Levy, J., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000175905.00212.2c · Cited by 363
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.25 · Cited by 362
Meta-analysis of probiotics for the treatment of irritable bowel syndrome
McFarland, L. V., & Dublin, S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2650 · Cited by 341
Microbes, immunoregulation, and the gut: Figure 1
Rook, G. A. W., & Brunet, L. R. (2005) · Gut · doi:10.1136/gut.2004.053785 · Cited by 334
Functional foods development: Trends and technologies
Betoret, E., Betoret, N., Vidal, D., & Fito, P. (2011) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2011.05.004 · Cited by 329
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 329
Ehrlich, A. M., Pacheco, A. R., Henrick, B. M., Taft, D., Xu, G., Huda, M. N., Mishchuk, D., Goodson, M. L., Slupsky, C., Barile, D., et al. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02023-y · Cited by 311
Resta–Lenert, S., & Barrett, K. E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.015 · Cited by 310
The role of gut-associated lymphoid tissues and mucosal defence
Forchielli, M. L., & Walker, W. A. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041356 · Cited by 304
Ma, D., Forsythe, P., & Bienenstock, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5308-5314.2004 · Cited by 289
Konieczna, P., Groeger, D., Ziegler, M., Frei, R., Ferstl, R., Shanahan, F., Quigley, E. M. M., Kiely, B., Akdis, C. A., & O'Mahony, L. (2012) · Gut · doi:10.1136/gutjnl-2011-300936 · Cited by 284
Self-citationO'Hara, A. M., O'Regan, P., Fanning, Á., O'Mahony, C., MacSharry, J., Lyons, A., Bienenstock, J., O'Mahony, L., & Shanahan, F. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02358.x · Cited by 283
Self-citationGenomic Insights into Bifidobacteria
Lee, J.-H., & O'Sullivan, D. J. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00004-10 · Cited by 281
Mileti, E., Matteoli, G., Iliev, I. D., & Rescigno, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007056 · Cited by 272
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez-Humarán, L. G. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-71 · Cited by 270
A Multihit Model: Colitis Lessons from the Interleukin-10–deficient Mouse
Keubler, L. M., Buettner, M., Häger, C., & Bleich, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000468 · Cited by 257
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 257
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T., Maaser, C., Lügering, A., Kagnoff, M., Mayer, L., Targan, S., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254
Microbiome as a therapeutic target in alcohol-related liver disease
Sarin, S. K., Pande, A., & Schnabl, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.019 · Cited by 253
Kamiya, T., Wang, L., Forsythe, P., Goettsche, G., Mao, Y., Wang, Y., Tougas, G., & Bienenstock, J. (2006) · Gut · doi:10.1136/gut.2005.070987 · Cited by 242
Prebiotics and probiotics; modifying and mining the microbiota
Quigley, E. M. M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.004 · Cited by 238
Kwon, H.-K., Kim, G.-C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.-E., Nam, J. H., & Im, S.-H. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.001 · Cited by 212
Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation
Riedel, C. U. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i23.3729 · Cited by 210
Carroll, I. M., Andrus, J. M., Bruno-Bárcena, J. M., Klaenhammer, T. R., Hassan, H. M., & Threadgill, D. S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2007 · Cited by 208
Health‐beneficial effects of probiotics: Its mode of action
OHASHI, Y., & USHIDA, K. (2009) · Animal Science Journal · doi:10.1111/j.1740-0929.2009.00645.x · Cited by 209
NIV, E., NAFTALI, T., HALLAK, R., & VAISMAN, N. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.06.001 · Cited by 191
Review article: probiotics and prebiotics in irritable bowel syndrome
SPILLER, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03750.x · Cited by 190
Immunomodulation by commensal and probiotic bacteria
Forsythe, P., & Bienenstock, J. (2010) · Immunological Investigations · doi:10.3109/08820131003667978 · Cited by 189
Alcohol or gut microbiota: who is the guilty?
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184568 · Cited by 183
Mucosal cytokine imbalance in irritable bowel syndrome
Macsharry, J., O'Mahony, L., Fanning, A., Bairead, E., Sherlock, G., Tiesman, J., Fulmer, A., Kiely, B., Dinan, T. G., Shanahan, F., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802276127 · Cited by 174
Self-citationProbiotic Effects on Inflammatory Bowel Disease1,
Sheil, B., Shanahan, F., & O’Mahony, L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.819s · Cited by 167
Self-citationQuigley, E. M. M., & Flourie, B. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00879.x · Cited by 151
A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract
Garrido, D., Barile, D., & Mills, D. A. (2012) · Advances in Nutrition · doi:10.3945/an.111.001586 · Cited by 149
Choi, C. H., Jo, S. Y., Park, H. J., Chang, S. K., Byeon, J.-S., & Myung, S.-J. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318204593e · Cited by 144
Stress matters: randomized controlled trial on the effect of probiotics on neurocognition
Papalini, S., Michels, F., Kohn, N., Wegman, J., van Hemert, S., Roelofs, K., Arias-Vasquez, A., & Aarts, E. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.100141 · Cited by 123
Camilleri, M. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00020 · Cited by 106
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8886 · Cited by 106
Microbiota abnormalities in inflammatory airway diseases — Potential for therapy
Gollwitzer, E. S., & Marsland, B. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.002 · Cited by 100
“Mousemodels of experimental colitis also demonstrated beneficial effects of several different probiotic strains, including L. casei, L. plantarum, B. longum and B. infantis (Schultz et al., 2002; McCarthy et al., 2003; Matsumoto et al., 2005).”
BackgroundKonieczna, P., Ferstl, R., Ziegler, M., Frei, R., Nehrbass, D., Lauener, R. P., Akdis, C. A., & O'Mahony, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062617 · Cited by 95
Yeh, T.-L., Shih, P.-C., Liu, S.-J., Lin, C.-H., Liu, J.-M., Lei, W.-T., & Lin, C.-Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s155110 · Cited by 93
The long-term health effects of neonatal microbial flora
Conroy, M. E., Shi, H. N., & Walker, W. A. (2009) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32832b3f1d · Cited by 83
Time to include the gut microbiota in the hygienic standardisation of laboratory rodents
Bleich, A., & Hansen, A. K. (2012) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2011.12.006 · Cited by 82
Using Probiotics in Gastrointestinal Disorders
Ringel, Y., Quigley, E. M., & Lin, H. C. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.7 · Cited by 77
Quigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67
Toumi, R., Abdelouhab, K., Rafa, H., Soufli, I., Raissi-Kerboua, D., Djeraba, Z., & Touil-Boukoffa, C. (2013) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2013.790413 · Cited by 68
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Dai, C., Guandalini, S., Zhao, D.-H., & Jiang, M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1126-5 · Cited by 60
Irritable bowel syndrome: a concise review of current treatment concepts
Wall, G. C., Bryant, G. A., Bottenberg, M. M., Maki, E. D., & Miesner, A. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.8796 · Cited by 56
Effects of Exopolysaccharide-Producing Probiotic Strains on Experimental Colitis in Rats
Şengül, N., Aslím, B., Uçar, G., Yücel, N., Işk, S., Bozkurt, H., Sakaoğullarí, Z., & Atalay, F. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0267-6 · Cited by 50
Oh, J. H., Jang, Y. S., Kang, D., Chang, D. K., & Min, Y. W. (2019) · Nutrients · doi:10.3390/nu11122887 · Cited by 45
“salivarius may influence immune regulation by increased induction of interleukin-10 (IL-10) [43], an anti-inflammatory cytokine, and reduced secretion of proinflammatory cytokines, such as tumor necrosis factor (TNF) alpha, IL-12, and interferon (IFN) gamma [44].”
BackgroundGut Microbiota–Host Interactions in Inborn Errors of Immunity
Castagnoli, R., Pala, F., Bosticardo, M., Licari, A., Delmonte, O. M., Villa, A., Marseglia, G. L., & Notarangelo, L. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031416 · Cited by 34
“When born and maintained in GF conditions, Il10−/− mice do not develop the spontaneous enterocolitis typical of the model [72], and similar effects have been observed when Il10−/− mice are treated with antibiotics since neonatal age [73].”
BackgroundProbiotic use in irritable bowel syndrome
Young, P., & Cash, B. D. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0053-1 · Cited by 22
The Use of Probiotics in Functional Bowel Disease
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20
“For example, oral administration of a Bifidobacterium exerted a profound anti-inflammatory effect in the IL-10 knock-out mouse, a potent model of IBD that was associated with suppression of the proinflammatory cytokines IFNc, tumor necrosis factor (TNF)-a, and IL12, while preserving activity of the anti-inflammatory c…”
BackgroundProbiotics in irritable bowel syndrome: an immunomodulatory strategy?
Quigley, E. M. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719648 · Cited by 19
Immunological Effects of Probiotics and their Significance to Human Health
Gill, H. S., Grover, S., Batish, V. K., & Gill, P. (2009) · Prebiotics and Probiotics Science and Technology · doi:10.1007/978-0-387-79058-9_23 · Cited by 13
Probiotics: Origin, Products, and Regulations in India
Narula, A. (2021) · Microorganisms for Sustainability · doi:10.1007/978-981-16-1947-2_4 · Cited by 6
Metadata
- Authors
- McCarthy, J., O’Mahony, L., O’Callaghan, L., Sheil, B., Vaughan, E. E., Fitzsimons, N., Fitzgibbon, J., O’Sullivan, G. C., Kiely, B., Collins, J. K., & Shanahan, F.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-07
- Volume
- 52
- Issue
- 7
- Pages
- 975-980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2109509831
- Cited by
- 462
- References
- 32
- FWCI
- 58.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.